Systematic review with meta‐analysis: liver manifestations and outcomes in COVID‐19
Alimentary Pharmacology & Therapeutics2020Vol. 52(4), pp. 584–599
Citations Over TimeTop 10% of 2020 papers
Anand V. Kulkarni, Pramod Kumar, Harsh Vardhan Tevethia, Madhumita Premkumar, Juan Pablo Arab, Roberto Cândia, Rupjyoti Talukdar, Mithun Sharma, Xiaolong Qi, Padaki Nagaraja Rao, D. Nageshwar Reddy
Abstract
Elevated liver chemistries are common at presentation and during COVID-19. The severity of elevated liver chemistries correlates with the outcome of COVID-19. The presence of CLD does not alter the outcome of COVID-19. Further studies are needed to analyse the outcomes of compensated and decompensated liver disease.
Related Papers
- → The reproductive number of COVID-19 is higher compared to SARS coronavirus(2020)3,461 cited
- → 2019 Novel Coronavirus (2019-nCoV) Pneumonia(2020)159 cited
- → Racing Towards the Development of Diagnostics for a Novel Coronavirus (2019-nCoV)(2020)32 cited
- → Wearing masks and the fight against the novel coronavirus (COVID-19)(2020)7 cited